Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination

Medicine & Life Sciences

• protein S precursor 100%
• Salmonella typhi 69%
• Salmonella typhimurium 61%
• Hepatitis B Core Antigens 60%
• Hepatitis B virus 51%
• Vaccination 42%
• Plasmids 28%
• Immunization 22%
• Vaccines 20%
• Immunoglobulin G 13%
• Nucleocapsid 11%
• Genes 10%
• Gene Deletion 9%
• Tissue Distribution 9%
• Lymphoid Tissue 9%
• Salmonella 9%
• Microbial Drug Resistance 8%
• Serum 8%
• Virulence 7%
• Lipopolysaccharides 7%
• Spleen 6%
• Viruses 5%
• Antigens 5%
• Gene Expression 5%
• Antibodies 4%

Agriculture & Biology

• oral vaccination 75%
• Hepatitis B virus 74%
• Salmonella Typhi 67%
• Salmonella Typhimurium 51%
• plasmids 27%
• vaccines 22%
• immunoglobulin G 21%
• proteins 18%
• mutants 15%
• heterologous gene expression 11%
• nucleocapsid 11%
• immunogenicity 10%
• gene deletion 10%
• tissue distribution 9%
• genes 9%
• neutralization 9%
• lethal genes 8%
• antibiotic resistance 8%
• lipopolysaccharides 8%
• Salmonella 7%
• spleen 7%
• digestive system 7%
• virulence 7%
• mouth 6%
• antigens 6%
• antibodies 5%
• viruses 5%
• mice 5%
• tissues 3%